Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE40812 | UPSHER SMITH LABS | Nasal calcitonin formulation |
Feb, 2021
(3 years ago) | |
USRE43580 | UPSHER SMITH LABS | Nasal calcitonin formulations |
Feb, 2021
(3 years ago) | |
US6440392 | UPSHER SMITH LABS | Nasal calcitonin formulations |
Feb, 2021
(3 years ago) |
Market Authorisation Date: 12 August, 2005
Treatment: Nasal administration
Dosage: SPRAY, METERED;NASAL